For millions of Americans, the new class of GLP-1 weight-loss drugs are as close to a miracle as modern medicine gets. Sold under brand names like Wegovy and Zepbound, these drugs have proven astoundingly successful at helping patients shed pounds.
Unfortunately, a number of unscrupulous companies have sought to capitalize on the growing demand for GLP-1s in ways putting patients at serious risk of harm. Many of these operations — including telehealth services and online pharmacies — are making their own unapproved versions of these medicines and leading patients to believe they’re buying the genuine article.
To date, regulators have been sluggish in shielding patients from the dangers of unapproved GLP-1s. But Americans can no longer afford to wait for federal action. Consumer advocates, drug makers, and healthcare providers need to raise awareness of this growing threat — and pressure regulators to step in.
Read more at Newsmax© 2025 Newsmax. All rights reserved.